BackPascal Biosciences Overview

Pascal Biosciences Operating Income

Track Pascal Biosciences's operating income ($-350K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-19674.00
↓ 457.97% YoY

As of May 31, 2026

Annual Operating Income (TTM)

$-349382.00
↑ 426.94% YoY

Trailing 12 months ending May 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Pascal Biosciences (PSCBF) FAQ

As of the most recent data (May 2026), PSCBF shows a operating income of $-350K. That compares with $-66K in the prior-year period — down 426.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PSCBF's operating income is now $-350K (was $-66K) — a 426.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pascal Biosciences is outperforming or lagging.

Tracking PSCBF's operating income over time shows whether Pascal Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $-350K That compares with $-66K in the prior-year period — down 426.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Pascal Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-350K) with ownership activity and broader fundamentals.